Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

A randomized, placebo-controlled study of duloxetine for the treatment of children and adolescents with generalized anxiety disorder.

  • Authors : Strawn JR; University of Cincinnati, College of Medicine, and Cincinnati Children's Hospital Medical Center, Division of Child and Adolescent Psychiatry, Cincinnati. Electronic address: .; Prakash A

Subjects: Suicidal Ideation*; Anxiety Disorders/Anxiety Disorders/Anxiety Disorders/*drug therapy ; Duloxetine Hydrochloride/Duloxetine Hydrochloride/Duloxetine Hydrochloride/*administration & dosage

  • Source: Journal of the American Academy of Child and Adolescent Psychiatry [J Am Acad Child Adolesc Psychiatry] 2015 Apr; Vol. 54 (4), pp. 283-93. Date of Publisher: Elsevier Country of Publication: United States NLM ID: 8704565 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders.

Subjects: Anxiety Disorders/Anxiety Disorders/Anxiety Disorders/*drug therapy ; Anxiety Disorders/Anxiety Disorders/Anxiety Disorders/*epidemiology ; Attention Deficit Disorder with Hyperactivity/Attention Deficit Disorder with Hyperactivity/Attention Deficit Disorder with Hyperactivity/*drug therapy

  • Source: Journal of the American Academy of Child and Adolescent Psychiatry [J Am Acad Child Adolesc Psychiatry] 2005 May; Vol. 44 (5), pp. 418-27.Publisher: Elsevier Country of Publication: United States NLM ID: 8704565 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

An open-label trial of escitalopram in pervasive developmental disorders.

  • Authors : Owley T; Department of Psychiatry, University of Chicago MC 3077, 5841 South Maryland Avenue, Chicago, IL 60637, USA. ; Walton L

Subjects: Child Development Disorders, Pervasive/Child Development Disorders, Pervasive/Child Development Disorders, Pervasive/*drug therapy ; Citalopram/Citalopram/Citalopram/*administration & dosage ; Selective Serotonin Reuptake Inhibitors/Selective Serotonin Reuptake Inhibitors/Selective Serotonin Reuptake Inhibitors/*administration & dosage

  • Source: Journal of the American Academy of Child and Adolescent Psychiatry [J Am Acad Child Adolesc Psychiatry] 2005 Apr; Vol. 44 (4), pp. 343-8.Publisher: Elsevier Country of Publication: United States NLM ID: 8704565 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

Fluoxetine in children and adolescents with OCD: a placebo-controlled trial.

  • Authors : Liebowitz MR; New York State Psychiatric Institute, Department of Psychiatry, Columbia University, New York 10032, USA.; Turner SM

Subjects: Fluoxetine/Fluoxetine/Fluoxetine/*therapeutic use ; Obsessive-Compulsive Disorder/Obsessive-Compulsive Disorder/Obsessive-Compulsive Disorder/*drug therapy ; Selective Serotonin Reuptake Inhibitors/Selective Serotonin Reuptake Inhibitors/Selective Serotonin Reuptake Inhibitors/*therapeutic use

  • Source: Journal of the American Academy of Child and Adolescent Psychiatry [J Am Acad Child Adolesc Psychiatry] 2002 Dec; Vol. 41 (12), pp. 1431-8.Publisher: Elsevier Country of Publication: United States NLM ID: 8704565 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

Sertraline pharmacokinetics and dynamics in adolescents.

  • Authors : Axelson DA; University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, PA 15213, USA. ; Perel JM

Subjects: Adolescent/Adolescent/Adolescent/*physiology ; Selective Serotonin Reuptake Inhibitors/Selective Serotonin Reuptake Inhibitors/Selective Serotonin Reuptake Inhibitors/*pharmacokinetics ; Sertraline/Sertraline/Sertraline/*pharmacokinetics

  • Source: Journal of the American Academy of Child and Adolescent Psychiatry [J Am Acad Child Adolesc Psychiatry] 2002 Sep; Vol. 41 (9), pp. 1037-44.Publisher: Elsevier Country of Publication: United States NLM ID: 8704565 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

Case study: caudate glutamatergic changes with paroxetine persist after medication discontinuation in pediatric OCD.

  • Authors : Bolton J; Department of Psychiatry, Wayne State University School of Medicine, Detroit, MI 48201, USA.; Moore GJ

Subjects: Caudate Nucleus/Caudate Nucleus/Caudate Nucleus/*drug effects ; Glutamic Acid/Glutamic Acid/Glutamic Acid/*metabolism ; Obsessive-Compulsive Disorder/Obsessive-Compulsive Disorder/Obsessive-Compulsive Disorder/*drug therapy

  • Source: Journal of the American Academy of Child and Adolescent Psychiatry [J Am Acad Child Adolesc Psychiatry] 2001 Aug; Vol. 40 (8), pp. 903-6.Publisher: Elsevier Country of Publication: United States NLM ID: 8704565 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial.

  • Authors : Keller MB; Department of Psychiatry and Human Behavior, Brown University School of Medicine, Providence, RI 02906, USA.; Ryan ND

Subjects: Depressive Disorder/Depressive Disorder/Depressive Disorder/*drug therapy ; Paroxetine/Paroxetine/Paroxetine/*therapeutic use ; Selective Serotonin Reuptake Inhibitors/Selective Serotonin Reuptake Inhibitors/Selective Serotonin Reuptake Inhibitors/*therapeutic use

  • Source: Journal of the American Academy of Child and Adolescent Psychiatry [J Am Acad Child Adolesc Psychiatry] 2001 Jul; Vol. 40 (7), pp. 762-72.Publisher: Elsevier Country of Publication: United States NLM ID: 8704565 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial.

  • Authors : Riddle MA; Division of Child and Adolescent Psychiatry, Johns Hopkins Hospital, CMSC 346, 600 North Wolfe Street, Baltimore, MD 21287-3325, USA. ; Reeve EA

Subjects: Fluvoxamine/Fluvoxamine/Fluvoxamine/*therapeutic use ; Obsessive-Compulsive Disorder/Obsessive-Compulsive Disorder/Obsessive-Compulsive Disorder/*drug therapy ; Selective Serotonin Reuptake Inhibitors/Selective Serotonin Reuptake Inhibitors/Selective Serotonin Reuptake Inhibitors/*therapeutic use

  • Source: Journal of the American Academy of Child and Adolescent Psychiatry [J Am Acad Child Adolesc Psychiatry] 2001 Feb; Vol. 40 (2), pp. 222-9.Publisher: Elsevier Country of Publication: United States NLM ID: 8704565 Publication Model: Print Cited Medium: Print

Record details

×
Report

Selective serotonin reuptake inhibitor-induced mydriasis.

Subjects: Mydriasis/Mydriasis/Mydriasis/*chemically induced ; Selective Serotonin Reuptake Inhibitors/Selective Serotonin Reuptake Inhibitors/Selective Serotonin Reuptake Inhibitors/*adverse effects; Adolescent

  • Source: Journal of the American Academy of Child and Adolescent Psychiatry [J Am Acad Child Adolesc Psychiatry] 2000 Feb; Vol. 39 (2), pp. 138-9.Publisher: Elsevier Country of Publication: United States NLM ID: 8704565 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

Paroxetine open-label treatment of pediatric outpatients with obsessive-compulsive disorder.

  • Authors : Rosenberg DR; Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, MI 48201, USA. ; Stewart CM

Subjects: Obsessive-Compulsive Disorder/Obsessive-Compulsive Disorder/Obsessive-Compulsive Disorder/*drug therapy ; Paroxetine/Paroxetine/Paroxetine/*therapeutic use ; Selective Serotonin Reuptake Inhibitors/Selective Serotonin Reuptake Inhibitors/Selective Serotonin Reuptake Inhibitors/*therapeutic use

  • Source: Journal of the American Academy of Child and Adolescent Psychiatry [J Am Acad Child Adolesc Psychiatry] 1999 Sep; Vol. 38 (9), pp. 1180-5.Publisher: Elsevier Country of Publication: United States NLM ID: 8704565 Publication Model: Print Cited Medium: Print

Record details

×
  • 1-10 of  17 results for ""Dose-Response Relationship, Drug""